Page last updated: 2024-08-26

nicotine and sr141716

nicotine has been researched along with sr141716 in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	33 (75.00)	29.6817
2010's	11 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Cohen, C; Perrault, G; Soubrié, P; Steinberg, R; Voltz, C	1
Cohen, C; Griebel, G; Perrault, G; Soubrié, P	1
Goldberg, SR; Le Foll, B	1
De Vries, TJ; de Vries, W; Janssen, MC; Schoffelmeer, AN	1
Forget, B; Hamon, M; Thiébot, MH	1
Camarelles Guillem, F	1
Borel, ML; Guevel-Jointret, AL; Mansourati, J; Munier, S	1
Aso, E; Balerio, GN; Maldonado, R	1
Corelli, RL; Hudmon, KS	1
Barthélémy, S; Forget, B; Hamon, M; Saurini, F; Thiébot, MH	1
Bumgarner, DM; Miller, DK; Putnam, WC; Rodvelt, KR	1
González-Cuevas, G; López-Moreno, JA; Navarro, M	1
Bura, SA; Castañé, A; Ledent, C; Maldonado, R; Valverde, O	1
Frishman, WH	1
Cohen, C; Griebel, G; Kodas, E; Louis, C	1
Calabro, S; Kelsey, JE	1
Cahill, K; Lancaster, T; Stead, L	1
Wonnacott, S	1
Damaj, MI; Lichtman, AH; Martin, BR; Merritt, LL; Walters, C	1
Aubin, HJ; Forget, B; Goldberg, SR; Le Foll, B	1
Buchhalter, AR; Fant, RV; Henningfield, JE	1
De Vries, TJ; de Vries, W; Diergaarde, L; Raasø, H; Schoffelmeer, AN	1
Goldberg, SR; Luchicchi, A; Melis, M; Muntoni, AL; Pillolla, G; Pistis, M; Yasar, S	1
Chang, Y; Dale, LC; Gonzales, D; Lawrence, D; Rigotti, NA	1
Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M	1
Kwiatkowska, M; Limebeer, CL; Litt, DL; Parker, LA; Piomelli, D; Rock, EM	1
Biala, G; Budzynska, B; Staniak, N	1
Bushell, K; Huffman, JW; Martin, BR; Vann, RE; Warner, JA; Wiley, JL	1
Coen, KM; Forget, B; Le Foll, B	1
Bevins, RA; Lyford, GD; Murray, JE; Wells, NR	1
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T	1
Biala, G; Budzynska, B; Kruk, M	1
Baarendse, PJ; Trezza, V; Vanderschuren, LJ	1
Bhat, A; Crain, D	1
Coen, KM; Gamaleddin, I; Goldberg, SR; Le Foll, B; Makryannis, A; Vemuri, K; Wertheim, C; Zhu, AZ	1
Fang, Q; He, YY; Li, FQ; Li, YQ; Liu, JF; Lu, L; Wang, JS; Xue, YX	1
Lecca, S; Luchicchi, A; Melis, M; Muntoni, AL; Pistis, M	1
Goldberg, SR; Justinova, Z; Makriyannis, A; Redhi, GH; Scherma, M; Schindler, CW; Vadivel, SK	1
Forget, B; Gamaleddin, I; Goldberg, SR; Guranda, M; Le Foll, B	1
Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K	1
Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R	1

Reviews

7 review(s) available for nicotine and sr141716

Article	Year
[Medications in smoking cessation]. Presse medicale (Paris, France : 1983), 2005, Oct-22, Volume: 34, Issue:18 Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Chewing Gum; Child; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Piperidines; Polymethacrylic Acids; Polyvinyls; Pyrazoles; Rimonabant; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices	2005
Pharmacologic interventions for smoking cessation. Critical care nursing clinics of North America, 2006, Volume: 18, Issue:1 Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline	2006
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations. Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline	2007
An update on therapeutics for tobacco dependence. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1 Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline	2008
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addiction biology, 2008, Volume: 13, Issue:2 Topics: Animals; Brain; Cannabinoid Receptor Modulators; Clinical Trials as Topic; Drug Evaluation, Preclinical; Emotions; Humans; Motivation; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder	2008
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status. Drugs, 2008, Volume: 68, Issue:8 Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Clonidine; Cytochrome P-450 CYP2A6; Drug Delivery Systems; GABA Modulators; Humans; Narcotic Antagonists; Nicotine; Piperidines; Pyrazoles; Receptors, Nicotinic; Rimonabant; Substance Withdrawal Syndrome; Tobacco Use Disorder; Vaccination	2008
Interventions for preventing weight gain after smoking cessation. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain	2009

Trials

1 trial(s) available for nicotine and sr141716

Article	Year
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain. Addiction (Abingdon, England), 2009, Volume: 104, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain; Young Adult	2009

Article

Year

A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.

Addiction (Abingdon, England), 2009, Volume: 104, Issue:2

Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Counseling; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Odds Ratio; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; Weight Gain; Young Adult

2009

Other Studies

36 other study(ies) available for nicotine and sr141716

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behavioural pharmacology, 2002, Volume: 13, Issue:5-6 Topics: Animals; Brain Chemistry; Central Nervous System Depressants; Discrimination Learning; Dopamine; Ethanol; Extracellular Space; Male; Microdialysis; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement, Psychology; Rimonabant; Self Administration	2002
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:1 Topics: Acoustic Stimulation; Animals; Cues; Dopamine; Environment; Extinction, Psychological; Light; Male; Motivation; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder	2005
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport, 2004, Sep-15, Volume: 15, Issue:13 Topics: Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant	2004
Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A. Behavioural brain research, 2005, Jun-03, Volume: 161, Issue:1 Topics: Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Inhibition, Psychological; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Sucrose; Sweetening Agents	2005
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology, 2005, Volume: 181, Issue:4 Topics: Animals; Association Learning; Conditioning, Psychological; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Motivation; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant	2005
[Medication for ending tobacco dependency. Current state]. Atencion primaria, 2005, Jun-30, Volume: 36, Issue:2 Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline	2005
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology, 2006, Volume: 184, Issue:3-4 Topics: Animals; Arousal; Conditioning, Classical; Dose-Response Relationship, Drug; Dronabinol; Fear; Male; Maze Learning; Mice; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2006
Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology, 2006, Volume: 189, Issue:1 Topics: Animals; Association Learning; Autoradiography; Behavior, Animal; Benzoxazines; Binding, Competitive; Brain; Cannabinoid Receptor Modulators; Conditioning, Classical; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors	2006
WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release. Life sciences, 2007, Jan-02, Volume: 80, Issue:4 Topics: Analgesics; Animals; Benzoxazines; Cannabinoid Receptor Antagonists; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; In Vitro Techniques; Male; Morpholines; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tritium	2007
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol. Neurobiology of disease, 2007, Volume: 25, Issue:2 Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Anxiety Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Male; Maze Learning; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Substance Withdrawal Syndrome; Sucrose	2007
Genetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes. British journal of pharmacology, 2007, Volume: 150, Issue:6 Topics: Animals; Avoidance Learning; Cognition; Male; Mice; Mice, Knockout; Nicotine; Physostigmine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Rimonabant; Scopolamine	2007
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling. Psychopharmacology, 2007, Volume: 194, Issue:2 Topics: Amygdala; Animals; Behavior, Addictive; Cannabinoid Receptor Modulators; Cerebral Cortex; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Endocannabinoids; Ganglionic Stimulants; Injections, Intravenous; Injections, Intraventricular; Limbic System; Male; Models, Anatomic; Motor Activity; Nicotine; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Self Administration; Signal Transduction; Time Factors	2007
Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats. Psychopharmacology, 2008, Volume: 198, Issue:4 Topics: Analysis of Variance; Animals; Body Weight; Cues; Injections, Intraperitoneal; Male; Motor Activity; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant	2008
Smoking cessation 2008. IDrugs : the investigational drugs journal, 2008, Volume: 11, Issue:4 Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline	2008
The endogenous cannabinoid system modulates nicotine reward and dependence. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:2 Topics: Animals; Cannabinoid Receptor Modulators; Conditioning, Psychological; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Reward; Rimonabant; Signal Transduction; Substance Withdrawal Syndrome; Tobacco Use Disorder	2008
Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A). Neuropharmacology, 2008, Volume: 55, Issue:5 Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoid Receptor Antagonists; Conditioning, Operant; Extinction, Psychological; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder	2008
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Dec-17, Volume: 28, Issue:51 Topics: Amides; Amidohydrolases; Animals; Appetite Depressants; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Dopamine; Endocannabinoids; Enzyme Activation; Enzyme Inhibitors; Ethanolamines; Injections, Intraventricular; Lipoxygenase Inhibitors; Male; Neurons; Nicotine; Oleic Acids; Organ Culture Techniques; Palmitic Acids; Patch-Clamp Techniques; Piperidines; PPAR alpha; Protein-Tyrosine Kinases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Rimonabant; Ventral Tegmental Area	2008
The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). Physiology & behavior, 2009, Apr-20, Volume: 97, Issue:1 Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Carbamates; Cisplatin; Drug Interactions; Endocannabinoids; Female; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Shrews; Vomiting	2009
Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Behavioural brain research, 2009, Sep-14, Volume: 202, Issue:2 Topics: Analysis of Variance; Animals; Central Nervous System Agents; Conditioning, Classical; Extinction, Psychological; Male; Morphine; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Spatial Behavior	2009
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice. European journal of pharmacology, 2009, Aug-01, Volume: 615, Issue:1-3 Topics: Amidohydrolases; Animals; Arachidonic Acids; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Hallucinogens; Male; Mice; Mice, Inbred C57BL; Nicotine; Phenylmethylsulfonyl Fluoride; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2009
Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade. Psychopharmacology, 2009, Volume: 205, Issue:4 Topics: Amidohydrolases; Animals; Behavior, Addictive; Benzamides; Carbamates; Enzyme Inhibitors; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Smoking	2009
Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats. Psychopharmacology, 2009, Volume: 205, Issue:4 Topics: Animals; Conditioning, Classical; Cyclohexanols; Discrimination Learning; Drug Interactions; Male; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant	2009
[Current and future medical drugs for smoking cessation]. Laryngo- rhino- otologie, 2009, Volume: 88, Issue:6 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline	2009
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009, Volume: 60, Issue:2 Topics: Animals; Anxiety; Benzoxazines; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ligands; Male; Maze Learning; Mice; Morpholines; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant	2009
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:12 Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior	2009
Current treatment options in smoking cessation. Hospital practice (1995), 2010, Volume: 38, Issue:1 Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline	2010
Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addiction biology, 2012, Volume: 17, Issue:1 Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Benzoxazines; Conditioning, Operant; Cues; Discrimination, Psychological; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Morpholines; Motivation; Motor Activity; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Rimonabant; Self Administration; Tobacco Use Disorder	2012
Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:4 Topics: Animals; Avoidance Learning; Conditioning, Operant; Male; Memory; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reward; Rimonabant	2011
Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:5 Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Cocaine; Dopaminergic Neurons; Electric Stimulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tegmentum Mesencephali; Time Factors; Ventral Tegmental Area	2012
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. Psychopharmacology, 2016, Volume: 233, Issue:10 Topics: Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cocaine; Dose-Response Relationship, Drug; Dronabinol; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reinforcement, Psychology; Reward; Rimonabant; Saimiri; Self Administration	2016
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats. Psychopharmacology, 2016, Volume: 233, Issue:10 Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Cues; Drug-Seeking Behavior; Endocannabinoids; Male; Nicotine; Piperidines; Polyunsaturated Alkamides; PPAR alpha; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tobacco Use Disorder	2016
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9 Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder	2016
CB Biological psychiatry, 2017, 04-01, Volume: 81, Issue:7 Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome	2017